Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2016: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2015: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2014: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Outline of Final Research Achievements |
It is well known that various proteins are relating to cancer. Among them, I focused on a disintegrin and metalloprotease 17 (ADAM17) and farnesyltransferase (FTase). We are successful to synthesis of a new pyridine /cysteamine based zinc chelator equipped with butynyloxybenzenesulfonyl group (as a ADAM17 inhibitor) or farnesyl group (as a FTase inhibitor) for recognition of these proteins. IC50 value of ADAM17 inhibitor against the THP-1 cell was 3.22μM, and IC50 value of FTase inhibitor against the dansyl-GCLVS was 0.90μM.
|